Penumbra Inc (STU:0P8)
€ 212.2 2.5 (1.19%) Market Cap: 8.20 Bil Enterprise Value: 8.14 Bil PE Ratio: 266.87 PB Ratio: 7.97 GF Score: 87/100

Penumbra Inc at Canaccord Genuity Growth Conference (Virtual) Transcript

Aug 11, 2021 / 03:00PM GMT
Release Date Price: €216.2 (-1.82%)
William John Plovanic
Canaccord Genuity Corp., Research Division - Analyst

Good morning. Welcome to the Canaccord Genuity Annual Growth Conference 2021. My name is Bill Plovanic. I'm one of the senior medical device analysts here at Canaccord. With us up next, we have Penumbra, and we have the President, CEO and Chairman, Adam Elsesser.

The format for today is going to be a fireside chat, and I'll remind everybody that we do have a web link that you can ask questions. You can also e-mail them to me as well at [email protected]. With that, I'm going to kick this off today. Adam, thank you for joining us.

Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO

My pleasure. Thanks for having us.

Questions & Answers

William John Plovanic
Canaccord Genuity Corp., Research Division - Analyst

And then just for -- I'd be surprised if people didn't know who Penumbra is, but actually, I have gotten some inquiries over the past week. So -- not very familiar with the company. Just give a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot